Invention Grant
US08497352B2 Use of Wnt5-α peptide derivates for the treatment of melanoma and gastric cancer
有权
使用Wnt5-α肽衍生物治疗黑色素瘤和胃癌
- Patent Title: Use of Wnt5-α peptide derivates for the treatment of melanoma and gastric cancer
- Patent Title (中): 使用Wnt5-α肽衍生物治疗黑色素瘤和胃癌
-
Application No.: US13058036Application Date: 2009-08-13
-
Publication No.: US08497352B2Publication Date: 2013-07-30
- Inventor: Tommy Andersson
- Applicant: Tommy Andersson
- Applicant Address: SE Lund
- Assignee: Wntresearch AB
- Current Assignee: Wntresearch AB
- Current Assignee Address: SE Lund
- Agency: Ladas & Parry LLP
- Priority: SE0801791 20080813
- International Application: PCT/SE2009/050935 WO 20090813
- International Announcement: WO2010/019103 WO 20100218
- Main IPC: C07K7/04
- IPC: C07K7/04 ; C07K7/06 ; C07K7/08 ; A61K38/04 ; A61P35/00
Abstract:
The present invention relates to a novel unbranched carbamate derivative, in particular N-butyloxycarbonyl derivative of certain Wnt5-α peptides and to their use in the treatment of melanoma or gastric cancer, as well as a method for treating melanoma as well as a pharmaceutical composition comprising the same derivative.
Public/Granted literature
- US20120010151A1 USE OF WNT5-A PEPTIDE DERIVATES FOR THE TREATMENT OF MELANOMA AND GASTRIC CANCER Public/Granted day:2012-01-12
Information query
